Insider plans sale of 2,000 BRKR shares

A holder of BRKR common stock has filed a notice to sell 2,000 shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $73,880.

Rhea-AI Filing Summary

A holder of BRKR common stock has filed a notice to sell 2,000 shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $73,880. The shares are listed on NASDAQ, and the filing states 151,941,144 shares of this class are outstanding.

The 2,000 shares to be sold were acquired on 02/13/2026 via a stock option exercise from the issuer, paid in cash the same day. The person named in recent activity, Mark R. Munch, has already sold common shares in the past three months, including 2,000 shares on 01/15/2026 for $98,400, 7,000 shares on 01/12/2026 for $385,000, and 33,843 shares on 01/05/2026 for $1,680,704.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the latest Form 144 filing indicate for BRKR?

The Form 144 shows an intention to sell 2,000 BRKR common shares through Morgan Stanley Smith Barney LLC. These shares were acquired via a stock option exercise on 02/13/2026 and are part of routine insider trading disclosure requirements.

How many BRKR shares are covered by the planned sale in this notice?

The notice covers a proposed sale of 2,000 BRKR common shares. The filing lists an aggregate market value of $73,880 for this block, indicating the approximate dollar size of the intended transaction relative to the issuer’s publicly traded stock.

How were the BRKR shares in the Form 144 acquired by the seller?

The 2,000 BRKR shares were acquired on 02/13/2026 through a stock option exercise from the issuer. The filing states that the purchase price was paid in cash on the same date, which is a common method for exercising employee or executive stock options.

What recent BRKR stock sales has Mark R. Munch reported?

The filing lists Mark R. Munch selling BRKR common shares in three transactions: 33,843 shares on 01/05/2026 for $1,680,704, 7,000 shares on 01/12/2026 for $385,000, and 2,000 shares on 01/15/2026 for $98,400.

How many BRKR shares are outstanding according to the Form 144?

The Form 144 states that there are 151,941,144 BRKR common shares outstanding. This figure provides context for the relative size of the 2,000-share planned sale and the prior sales reported during the last three months by the same individual.

On which exchange are the BRKR shares in this filing traded?

The BRKR common shares referenced in the Form 144 are listed on the NASDAQ stock market. The filing identifies NASDAQ as the relevant securities exchange for the planned 2,000-share sale through Morgan Stanley Smith Barney LLC Executive Financial Services.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 04:28 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001544635
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Bruker Corporation
SEC File Number	001-42828
Address of Issuer	40 Manning Road Billerica, MASSACHUSETTS 01821
Phone	978-663-3660
Name of Person for Whose Account the Securities are To Be Sold	MARK R MUNCH
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2000	73880.00	151941144	02/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/13/2026	Stock Option Exercise	ISSUER			2000	02/13/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MARK R MUNCH 40 Manning Road Billerica, MA 01821	Common	01/15/2026	2000	98400.00
MARK R MUNCH 40 Manning Road Billerica, MA 01821	Common	01/12/2026	7000	385000.00
MARK R MUNCH 40 Manning Road Billerica, MA 01821	Common	01/05/2026	33843	1680704.00

144: Remarks and Signature

Remarks
Date of Notice	02/13/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Mark Munch
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)